NeuroScientific Biopharmaceuticals Limited (ASX:NSB)

Australia flag Australia · Delayed Price · Currency is AUD
0.1150
0.00 (0.00%)
Apr 17, 2026, 2:09 PM AEST
Market Cap38.25M +545.1%
Revenue (ttm)317.91K -85.6%
Net Income-3.18M
EPS-0.01
Shares Out332.58M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume130,990
Average Volume483,170
Open0.1150
Previous Close0.1150
Day's Range0.1100 - 0.1200
52-Week Range0.0450 - 0.2600
Beta1.11
RSI58.76
Earnings DateMay 26, 2026

About ASX:NSB

NeuroScientific Biopharmaceuticals Limited engages in the research and development of biomedical products targeting neurodegenerative conditions. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Perth, Australia. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol NSB
Full Company Profile

Financial Performance

Financial Statements